RxDoctor Payments Data

Megan McLuckie, NP

Primary Care · Hoffman Estates, ILNPI 1538873864

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.2% of the total across 360 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 25.6% of the total. Among primary care clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,593in general payments, 2019–2025

Across 360 payments — averaging $23.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Lilly USA, LLC$966
  • Johnson & Johnson$940
  • Sun Pharmaceutical Industries Inc.$828
  • Regeneron Healthcare Solutions, Inc.$741
  • Sanofi$597
  • plus $2K from 22 others

What the payments were for

  • Food & beverage$8,35697%
  • Education$2373%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,593 in reported general payments places this provider in the 95th percentile of 150 primary care providers in Illinois.

See all primary care providers in Illinois

Medicare billing

Part B allowed, 2024
$104,335
Medicare patients
520
Services billed
2,058

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate37$2,222
Betamethasone Dipropionate45$2,016
Ketoconazole63$1,061
Metronidazole11$715
Doxycycline Hyclate15$705
Triamcinolone Acetonide80$575
Clindamycin Phosphate14$387
Mupirocin49$284
Doxycycline Monohydrate22$261
Hydrocortisone41$178
ValacyclovirValacyclovir Hcl16$139

Paid to pharmacies, not to this prescriber.

Other primary care in Hoffman Estates

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →